References
1. Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 2015: 16(1): 45-56.
2. Doull I. Devil in the detail of newborn screening for cystic fibrosis. Arch Dis Child 2018.
3. Guglani L. Changing the Paradigm - Treating the Basic Defect in Cystic Fibrosis. Indian J Pediatr 2015: 82(8): 727-736.
4. Schwiebert EM, Benos DJ, Fuller CM. Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein. Am J Med 1998: 104(6): 576-590.
5. Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006: 173(5): 475-482.
6. Roesch EA, Nichols DP, Chmiel JF. Inflammation in cystic fibrosis: An update. Pediatr Pulmonol 2018: 53(S3): S30-S50.
7. Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, Murray CP, Stick SM, Investigators AC. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013: 368(21): 1963-1970.
8. Garratt LW, Sutanto EN, Ling KM, Looi K, Iosifidis T, Martinovich KM, Shaw NC, Kicic-Starcevich E, Knight DA, Ranganathan S, Stick SM, Kicic A. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.Eur Respir J 2015: 46(2): 384-394.
9. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A 2008: 105(11): 4335-4339.
10. Forrest OA, Ingersoll SA, Preininger MK, Laval J, Limoli DH, Brown MR, Lee FE, Bedi B, Sadikot RT, Goldberg JB, Tangpricha V, Gaggar A, Tirouvanziam R. Frontline Science: Pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis.Journal of leukocyte biology 2018: 104(4): 665-675.
11. Margaroli C, Garratt LW, Horati H, Dittrich AS, Rosenow T, Montgomery ST, Frey DL, Brown MR, Schultz C, Guglani L, Kicic A, Peng L, Scholte BJ, Mall MA, Janssens HM, Stick SM, Tirouvanziam R. Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis. Am J Respir Crit Care Med 2019: 199(7): 873-881.
12. Turkovic L, Caudri D, Rosenow T, Breuer O, Murray C, Tiddens H, Ramanauskas F, Ranganathan SC, Hall GL, Stick SM. Structural determinants of long-term functional outcomes in young children with cystic fibrosis. Eur Respir J 2020: 55(5).
13. Fayon M, Kent L, Bui S, Dupont L, Sermet I. Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis.Eur Respir J 2014: 43(2): 610-626.
14. Stafler P, Davies JC, Balfour-Lynn IM, Rosenthal M, Bush A. Bronchoscopy in cystic fibrosis infants diagnosed by newborn screening.Pediatr Pulmonol 2011: 46(7): 696-700.
15. De Boeck K, Alifier M, Vandeputte S. Sputum induction in young cystic fibrosis patients. Eur Respir J 2000: 16(1): 91-94.
16. Henig NR, Tonelli MR, Pier MV, Burns JL, Aitken ML. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax 2001: 56(4): 306-311.
17. Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT. The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.Lancet Respir Med 2018: 6(6): 461-471.
18. Ranganathan SC, Hall GL, Sly PD, Stick SM, Douglas TA. Early lung disease in infants and preschool children with cystic fibrosis. What have we learned and what should we wo about it? Am J Respir Crit Care Med 2017: 195(12): 1567-1575.
19. Gutierrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, Robertson CF, Phelan PD. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis.Eur Respir J 2001: 17(2): 281-286.
20. Meyer KC, Sharma A. Regional variability of lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 1997: 156(5): 1536-1540.
21. Giacalone VD, Margaroli C, Dobosh B, Brown MR, Silva GL, Peng L, Chandler JD, Tirouvanziam R, Guglani L. Induced sputum as an alternative to broncholaveolar lavage for evaluation of airway inflammation in young children with cystic fibrosis. In: The 33rd Annual North American Cystic Fibrosis Conference; 2019; Nashville, TN: Pediatr. Pulmonol; 2019. p. 157-158.
22. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, Robertson CF, Ranganathan SC, Sly PD, Stick SM, Arest CF. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012: 67(6): 509-516.
23. Rosenow T, Oudraad MC, Murray CP, Turkovic L, Kuo W, de Bruijne M, Ranganathan SC, Tiddens HA, Stick SM. PRAGMA-CF: a quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med 2015: 191(10): 1158-1165.
24. Tirouvanziam R, Diaz D, Gernez Y, Laval J, Crubezy M, Makam M. An Integrative Approach for Immune Monitoring of Human Health and Disease by Advanced Flow Cytometry Methods. Advanced Optical Flow Cytometry. Wiley-VCH Verlag GmbH & Co. KGaA, 2011; pp. 333-362.
25. Gehrig S, Mall MA, Schultz C. Spatially resolved monitoring of neutrophil elastase activity with ratiometric fluorescent reporters.Angew Chem Int Ed Engl 2012: 51(25): 6258-6261.
26. Gehrig S, Duerr J, Weitnauer M, Wagner CJ, Graeber SY, Schatterny J, Hirtz S, Belaaouaj A, Dalpke AH, Schultz C, Mall MA. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.Am J Respir Crit Care Med 2014: 189(9): 1082-1092.
27. Dittrich AS, Kuhbandner I, Gehrig S, Rickert-Zacharias V, Twigg M, Wege S, Taggart CC, Herth F, Schultz C, Mall MA. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis. Eur Respir J 2018: 51(3).
28. Jundi K, Greene CM. Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease. Biomolecules2015: 5(3): 1386-1398.
29. Krenn K, Klepetko W, Taghavi S, Paulus P, Aharinejad S. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation. Eur J Cardiothorac Surg 2007: 32(1): 35-41.
30. Iannitti RG, Napolioni V, Oikonomou V, De Luca A, Galosi C, Pariano M, Massi-Benedetti C, Borghi M, Puccetti M, Lucidi V, Colombo C, Fiscarelli E, Lass-Florl C, Majo F, Cariani L, Russo M, Porcaro L, Ricciotti G, Ellemunter H, Ratclif L, De Benedictis FM, Talesa VN, Dinarello CA, van de Veerdonk FL, Romani L. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat Commun 2016: 7: 10791.
31. Montgomery ST, Mall MA, Kicic A, Stick SM. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J 2017: 49(1).
32. Margaroli C, Tirouvanziam R. Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease. Mol Cell Pediatr 2016: 3(1): 38.
33. Chandler JD, Margaroli C, Horati H, Kilgore MB, Veltman M, Liu HK, Taurone AJ, Peng L, Guglani L, Uppal K, Go YM, Tiddens H, Scholte BJ, Tirouvanziam R, Jones DP, Janssens HM. Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease. Eur Respir J 2018: 52(4).
34. Giacalone VD, Moncada Giraldo D, Tirouvanziam R. Inflammatory biomarkers in induced sputum from young children with cystic fibrosis.Mendeley Data 2021: doi: 10.17632/dsyp24db7h.1.